AC Immune (ACIU) Capital Expenditures (2015 - 2025)
AC Immune (ACIU) recorded Capital Expenditures of -$133,875 in the quarter ended Dec 31, 2025, compared with -$102,737 a year earlier.
Powered by 
Analysis
AC Immune (ACIU) Capital Expenditures (2015 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, AC Immune reported Capital Expenditures of -$1.09 million.
- Across earlier years, Capital Expenditures came in at -$654,740 in the year ended Dec 31, 2024, -$891,868 in the year ended Dec 31, 2023, -$1.3 million in the year ended Dec 31, 2022 and -$2.88 million in the year ended Dec 31, 2021.
- Quarterly Capital Expenditures has ranged from -$873,787 in the quarter ended Mar 31, 2021 to -$42,559 in the quarter ended Dec 31, 2022 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$72,506 (quarter ended Sep 30, 2025), -$450,543 (quarter ended Jun 30, 2025) and -$402,635 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | AC Immune | 264.53 Mn | 264.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -133,875.17 |
| Sep 30, 2025 | -72,506.35 |
| Jun 30, 2025 | -450,543.06 |
| Mar 31, 2025 | -402,634.69 |
| Dec 31, 2024 | -102,736.97 |
| Sep 30, 2024 | -195,061.02 |
| Jun 30, 2024 | -75,193.96 |
| Mar 31, 2024 | -285,274.90 |
| Dec 31, 2023 | -187,140.84 |
| Sep 30, 2023 | -317,002.72 |
| Jun 30, 2023 | -172,387.21 |
| Mar 31, 2023 | -216,232.52 |
| Dec 31, 2022 | -42,558.90 |
| Sep 30, 2022 | -125,290.25 |
| Jun 30, 2022 | -557,563.34 |
| Mar 31, 2022 | -584,716.52 |
| Dec 31, 2021 | -783,010.51 |
| Sep 30, 2021 | -539,118.91 |
| Jun 30, 2021 | -688,694.39 |
| Mar 31, 2021 | -873,786.66 |
API Access
AC Immune Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();